MoreThe H.C. Starck Group has sold its silica sol business in Leverkusen, Germany, to Akzo Nobel Chemicals GmbH, Düren, Germany. The acquisition price was not disclosed. “We are convinced that the silica sol business continues to have very attractive growth possibilities under the ownership of Akzo Nobel,” said Heinz Heumueller, Ph.D., chief executive officer of the H.C. Starck Group. The companies concluded the contracts on April 30, 2008. The sale is subject to the approval by the antitrust authorities.
“This strategically important acquisition will enable us to enter a number of additional silica sol markets, primarily in Europe,” said Rob Frohn, Akzo Nobel’s board member responsible for Specialty Chemicals. “Our streamlined chemicals portfolio is primed for investment and this transaction emphasizes our commitment to focusing on growth.”
“Akzo Nobel is the ideal partner for our future expansion,” said H.C. Starck Silica Sol’s Managing Directors Gabriele Hey, Ph.D., and Sven Marienfeld. “With the support of Akzo Nobel, we are well positioned continue to pursue our growth strategy.”
For more information, visit www.hcstarck.com or www.akzonobel.com.
“This strategically important acquisition will enable us to enter a number of additional silica sol markets, primarily in Europe,” said Rob Frohn, Akzo Nobel’s board member responsible for Specialty Chemicals. “Our streamlined chemicals portfolio is primed for investment and this transaction emphasizes our commitment to focusing on growth.”
“Akzo Nobel is the ideal partner for our future expansion,” said H.C. Starck Silica Sol’s Managing Directors Gabriele Hey, Ph.D., and Sven Marienfeld. “With the support of Akzo Nobel, we are well positioned continue to pursue our growth strategy.”
For more information, visit www.hcstarck.com or www.akzonobel.com.
With access to over one million professionals and more than 60 industry-specific publications,
